Press

The international derivatives exchange Eurex will be launching seven further German equity options on stocks from the MDAX^® and TecDAX^® indices on 21 May. The new options will use the following stocks as underlyings: Stada Arzneimittel, Q-Cells, Conergy, K+S, United Internet, GEA Group and Premiere.

The options will be included in Eurex’s market making program from the outset. This program gives market makers an incentive to quote these stocks on a permanent basis. At the same time, it also ensures liquid trading in the new equity options. The contract specifications resemble the existing equity options.

The introduction of the equity options is Eurex’s way of meeting the growing demand among clients for derivatives on attractive mid cap stocks from MDAX^® and TecDAX^®. The increase in demand is fuelled, in particular, by ETF issuers, hedge funds, traditional investment funds and providers of warrants and certificates on German mid caps. Furthermore, the options on Gea Group, K+S, Q-Cells and Stada Arzneimittel complement the single stock futures that are already available on these stocks.

In the future, Eurex participants will have access to 58 equity options on German underlyings. Last year, this product segment achieved a trading volume of more than 180 million contracts traded, making Eurex the most liquid trading venue for German equity options. With the ongoing expansion of its service and product offering, Eurex is emphasizing its claim to the title of the world’s leading marketplace for exchange-traded derivatives.